http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-615149-A5
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-58 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-04 |
filingDate | 1977-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5357c91a2c395d6b3db06fbf8d34177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da23001a1b84da032f6e4684c2737673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac5147a2865a53d9345ef6aa0a693eb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49780b73b3c02328d15bee5036b473bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_703ad44902c66fca708de1d6dd99e790 |
publicationDate | 1980-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CH-615149-A5 |
titleOfInvention | Process for the preparation of novel aminophenylethanolamines |
abstract | Novel aminophenylethanolamines of the formula I shown, wherein the symbols R1, R2 and R3 have the meanings given in Patent Claim 1, and their physiologically tolerated acid addition salts with inorganic or organic acids, are prepared by reduction of compounds of the formula IIa shown, or by reduction of corresponding aldehydes, in the presence of amines. …<??>The products of the process may be obtained in the form of the racemates or in the form of their optically active antipodes. …<??>The compounds of the formula I have valuable pharmacological properties and, in addition to an analgesic action, uterus-spasmolytic action and anti-spastic action on striped muscle, in particular exhibit ss2-mimetic and/or ss1-blocking actions, with one or other action predominating depending on the substitution of the compounds. The d(+)-compounds in particular show a selective action on the ss1-receptors and the 1(-)-compounds show a preferred action on the ss2-receptors. …<IMAGE>… |
priorityDate | 1973-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.